These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 29329443)

  • 1. Bone formation in ankylosing spondylitis during anti-tumour necrosis factor therapy imaged by 18F-fluoride positron emission tomography.
    Bruijnen STG; Verweij NJF; van Duivenvoorde LM; Bravenboer N; Baeten DLP; van Denderen CJ; van der Horst-Bruinsma IE; Voskuyl AE; Custers M; van de Ven PM; Bot JCJ; Boden BJH; Lammertsma AA; Hoekstra OSH; Raijmakers PGHM; van der Laken CJ
    Rheumatology (Oxford); 2018 Apr; 57(4):631-638. PubMed ID: 29329443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone formation rather than inflammation reflects ankylosing spondylitis activity on PET-CT: a pilot study.
    Bruijnen ST; van der Weijden MA; Klein JP; Hoekstra OS; Boellaard R; van Denderen JC; Dijkmans BA; Voskuyl AE; van der Horst-Bruinsma IE; van der Laken CJ
    Arthritis Res Ther; 2012 Apr; 14(2):R71. PubMed ID: 22471910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of bone synthetic activity in inflammatory lesions and syndesmophytes in patients with ankylosing spondylitis: the potential role of 18F-fluoride positron emission tomography-magnetic resonance imaging.
    Lee SG; Kim IJ; Kim KY; Kim HY; Park KJ; Kim SJ; Park EK; Jeon YK; Yang BY; Kim GT
    Clin Exp Rheumatol; 2015; 33(1):90-7. PubMed ID: 25572626
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of Response to Tumor Necrosis Value-α Blocker Is Suggested by
    Kim K; Son SM; Goh TS; Pak K; Kim IJ; Lee JS; Kim SJ
    AJR Am J Roentgenol; 2020 Jun; 214(6):1352-1358. PubMed ID: 32286869
    [No Abstract]   [Full Text] [Related]  

  • 5. Baseline increased 18F-fluoride uptake lesions at vertebral corners on positron emission tomography predict new syndesmophyte development in ankylosing spondylitis: a 2-year longitudinal study.
    Park EK; Pak K; Park JH; Kim K; Kim SJ; Kim IJ; Kim GT; Lee SG
    Rheumatol Int; 2017 May; 37(5):765-773. PubMed ID: 28154899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive value of semi-quantitative index from F-18-fluoride PET/CT for treatment response in patients with ankylosing spondylitis.
    Lee SJ; Kim JY; Choi YY; Lee S; Joo YB; Kim TH
    Eur J Radiol; 2020 Aug; 129():109048. PubMed ID: 32446125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hybrid 18F-labeled Fluoride Positron Emission Tomography/Magnetic Resonance (MR) Imaging of the Sacroiliac Joints and the Spine in Patients with Axial Spondyloarthritis: A Pilot Study Exploring the Link of MR Bone Pathologies and Increased Osteoblastic Activity.
    Buchbender C; Ostendorf B; Ruhlmann V; Heusch P; Miese F; Beiderwellen K; Schneider M; Braun J; Antoch G; Baraliakos X
    J Rheumatol; 2015 Sep; 42(9):1631-7. PubMed ID: 26136491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-fluoride PET/CT for detection of axial involvement in ankylosing spondylitis: correlation with disease activity.
    Idolazzi L; Salgarello M; Gatti D; Viapiana O; Vantaggiato E; Fassio A; Adami S; Rossini M
    Ann Nucl Med; 2016 Jul; 30(6):430-4. PubMed ID: 27137206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [
    de Jongh J; Verweij NJF; Yaqub M; van Denderen CJ; van der Horst-Bruinsma IE; Bot JCJ; Boden BJH; Hemke R; Smithuis FF; Lems WF; Lammertsma AA; Voskuyl AE; Boers M; Zwezerijnen GJC; van der Laken CJ
    Eur J Nucl Med Mol Imaging; 2023 Apr; 50(5):1351-1359. PubMed ID: 36508028
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    de Jongh J; Hemke R; Zwezerijnen GJC; Yaqub M; van der Horst-Bruinsma IE; van de Sande MGH; van Kuijk AWR; Voskuyl AE; van der Laken CJ
    Eur J Nucl Med Mol Imaging; 2023 Feb; 50(3):756-764. PubMed ID: 36370181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resolution of inflammation following treatment of ankylosing spondylitis is associated with new bone formation.
    Pedersen SJ; Chiowchanwisawakit P; Lambert RG; Østergaard M; Maksymowych WP
    J Rheumatol; 2011 Jul; 38(7):1349-54. PubMed ID: 21459937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiographic damage and progression of the cervical spine in ankylosing spondylitis patients treated with TNF-α inhibitors: Facet joints vs. vertebral bodies.
    Maas F; Spoorenberg A; Brouwer E; van der Veer E; Bootsma H; Bos R; Wink FR; Arends S
    Semin Arthritis Rheum; 2017 Apr; 46(5):562-568. PubMed ID: 28040243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual-phase hybrid
    Sawicki LM; Lütje S; Baraliakos X; Braun J; Kirchner J; Boos J; Heusch P; Ruhlmann V; Herrmann K; Umutlu L; Quick HH; Antoch G; Buchbender C
    J Med Imaging Radiat Oncol; 2018 Jun; 62(3):313-319. PubMed ID: 29067775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MRI in predicting a major clinical response to anti-tumour necrosis factor treatment in ankylosing spondylitis.
    Rudwaleit M; Schwarzlose S; Hilgert ES; Listing J; Braun J; Sieper J
    Ann Rheum Dis; 2008 Sep; 67(9):1276-81. PubMed ID: 18006539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous long-term anti-TNF therapy does not lead to an increase in the rate of new bone formation over 8 years in patients with ankylosing spondylitis.
    Baraliakos X; Haibel H; Listing J; Sieper J; Braun J
    Ann Rheum Dis; 2014 Apr; 73(4):710-5. PubMed ID: 23505240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the diagnostic performance of
    Son SM; Kim K; Pak K; Kim SJ; Goh TS; Lee JS
    Spine J; 2020 Sep; 20(9):1471-1479. PubMed ID: 32198119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor α inhibition in radiographic and nonradiographic axial spondyloarthritis: results from a large observational cohort.
    Ciurea A; Scherer A; Exer P; Bernhard J; Dudler J; Beyeler B; Kissling R; Stekhoven D; Rufibach K; Tamborrini G; Weiss B; Müller R; Nissen MJ; Michel BA; van der Heijde D; Dougados M; Boonen A; Weber U;
    Arthritis Rheum; 2013 Dec; 65(12):3096-106. PubMed ID: 23983141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relationship between inflammation and new bone formation in patients with ankylosing spondylitis.
    Baraliakos X; Listing J; Rudwaleit M; Sieper J; Braun J
    Arthritis Res Ther; 2008; 10(5):R104. PubMed ID: 18761747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physical Function and Spinal Mobility Remain Stable Despite Radiographic Spinal Progression in Patients with Ankylosing Spondylitis Treated with TNF-α Inhibitors for Up to 10 Years.
    Poddubnyy D; Fedorova A; Listing J; Haibel H; Baraliakos X; Braun J; Sieper J
    J Rheumatol; 2016 Dec; 43(12):2142-2148. PubMed ID: 27803139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focal fat lesions at vertebral corners on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis.
    Chiowchanwisawakit P; Lambert RG; Conner-Spady B; Maksymowych WP
    Arthritis Rheum; 2011 Aug; 63(8):2215-25. PubMed ID: 21484769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.